Evidence map›Paper›PMID 42439551›Full record

ArticleJournal of virology2026

GC content mismatch of transgene destabilizes RNA virus genomes.

Sachiho Kawahara, Naganori Nao, Sarun Tulakarnwong, Saori Suzuki, Rigel Suzuki, Sarin Chimnaronk, Tomokazu Tamura, Takasuke Fukuhara

Abstract read
In one paragraph

Article in Journal of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sachiho KawaharaSchool of Medicine, Hokkaido University, Sapporo, Japan.ORCID 0009-0000-8384-0969
Naganori NaoOne Health Research Center, Hokkaido University, Sapporo, Japan.
Sarun TulakarnwongInstitute of Molecular Biosciences, Mahidol University, Salaya, Nakhon Pathom, Thailand.ORCID 0000-0003-4072-2502
Saori SuzukiSchool of Medicine, Hokkaido University, Sapporo, Japan.
Rigel SuzukiSchool of Medicine, Hokkaido University, Sapporo, Japan.
Sarin ChimnaronkInstitute of Molecular Biosciences, Mahidol University, Salaya, Nakhon Pathom, Thailand.ORCID 0000-0001-6113-3681
Tomokazu TamuraSchool of Medicine, Hokkaido University, Sapporo, Japan.ORCID 0000-0003-1395-6610
Takasuke FukuharaSchool of Medicine, Hokkaido University, Sapporo, Japan.ORCID 0000-0001-5471-8331

Funding

Akiyama Life Science FoundationAMED CREST JP22gm1610008Grants-in-Aid for R&D of Young Scientists from Northern Advancement Center for Science & Technology (NOASTEC) of Hokkaido T-1-26Health Systems Research Institute HSRI 64-152Heiwa Nakajima FoundationHokkaido University Support Program for Frontier ResearchHokuto Foundation for BioscienceIchiro Kanehara Foundation for the Promotion of Medical Sciences and Medical CareInamori FoundationJapan Agency for Medical Research and Development JP223fa627005 to T.F., JP22fk0108617 to T.F, JP22fk0108617 to T.T., JP23fk0108598 to T.T., JP24wm0325073 to T.T., JP23wm0125012 to N.N., JP24wm0225046 to N.N., JP25wm0125008 to N.N., JP25fk0210183 to N.N.Japan Foundation for Applied EnzymologyJapan Health FoundationJapan Society for the Promotion of Science JP26H02418 to T.F., JP21H02736 to T.F., JP23K20041 to T.F., JP24K09259 to T.T., JP25K11734 to N.N.Keieikai Research FoundationKobayashi FoundationKowa Life Science FoundationMochida Memorial Foundation for Medical and Pharmaceutical ResearchNakatani FoundationNIAID/AMED Infectious Diseases and Immunology Research: U.S.-Japan Cooperative Medical Sciences Program (USJCMSP) JP25jk0210052Oshimo FoundationResearch Foundation for Opt-Science and TechnologyShionogi Infectious Diseases Research Promotion FoundationTakeda Science FoundationThe Foundation for The Advancement of Clinical MedicineThe Ito FoundationTOBE MAKI FoundationToyota Physical and Chemical Research Institute
6 · The paper itself

Abstract

GC content-the proportion of guanine and cytosine nucleotides-varies widely among organisms and viruses. Although GC content is recognized to have biological significance, its functional role in viruses remains poorly understood. Here, we examined the impact of GC-content bias using three positive-sense single-stranded RNA viruses with distinct GC profiles: severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), Japanese encephalitis virus (JEV), and hepatitis C virus (HCV). Variants of the NanoLuc (Nluc) reporter gene, engineered with synonymous mutations to alter GC content, were inserted into each viral genome. Serial passaging experiments revealed strong effects on genome stability and viral fitness. In SARS-CoV-2, which has low GC content, the introduction of a GC-rich Nluc gene disrupted genome stability, leading to frequent deletions of Nluc. In both SARS-CoV-2 and HCV, Nluc with mismatched GC levels accumulated substitutions that optimized GC content toward that of the viral genome, predominantly at the third codon position. tRNA-seq analysis revealed a shift in the host tRNA pool toward a more GC-rich composition during HCV infection, consistent with this substitution bias. In contrast, JEV (intermediate GC content) maintained the Nluc variants across serial passages, suggesting reduced selective pressure. Taken together, these findings demonstrate that mismatches between viral genome GC content and inserted sequences profoundly affect genetic stability, suggesting evolutionary constraints that may shape RNA virus composition more broadly. This study provides mechanistic insight into how GC content influences viral genome maintenance and offers a framework for designing genetically stable recombinant reporter viruses.IMPORTANCEGC content is a fundamental genomic feature that influences gene expression, genome architecture, and adaptation. Although its role in cellular genomes has been extensively studied, the functional significance of GC content in viral genomes remains poorly understood. In this study, we show that incompatibility in GC content between a viral genome and an inserted transgene destabilizes RNA secondary structures, compromising viral genome integrity, and is accompanied by changes in the host tRNA pool consistent with this compositional bias. These findings identify GC content as a previously underappreciated determinant of virus-host compatibility and viral fitness. Importantly, our results provide mechanistic insight into how the GC content of a viral genome can be matched to its host cellular environment. By demonstrating that GC content matching is critical for the stability of recombinant viruses, this study provides a basis for the rational design of reporter viruses, vaccine platforms, and antiviral screening tools.

Indexed as

Genome, ViralGenomic InstabilityRNA, ViralRNA VirusesSARS-CoV-2TransgenesAnimalsBase CompositionGenes, ReporterHepacivirusHumansRNA, TransferRNA, TransferRNA, Viralcodon usageGC contentreportersRNA structureRNA viruses

Identifiers

PMID42439551
PMCPMC13483392

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.